14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.612 $13.48 Wednesday, 1st May 2024 ACOR stock ended at $0.661. During the day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661.
90 days $0.612 $16.74
52 weeks $0.470 $18.21

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
Feb 03, 2016 $37.88 $37.88 $37.88 $37.88 564 100
Feb 02, 2016 $37.17 $37.17 $37.17 $37.17 404 100
Feb 01, 2016 $37.92 $37.92 $37.92 $37.92 524 500
Jan 29, 2016 $36.82 $36.82 $36.82 $36.82 770 500
Jan 28, 2016 $36.29 $36.29 $36.29 $36.29 705 500
Jan 27, 2016 $37.78 $37.78 $37.78 $37.78 757 700
Jan 26, 2016 $38.96 $38.96 $38.96 $38.96 903 100
Jan 25, 2016 $39.89 $39.89 $39.89 $39.89 1 136 800
Jan 22, 2016 $38.00 $38.00 $38.00 $38.00 970 900
Jan 21, 2016 $37.51 $37.51 $37.51 $37.51 1 035 900
Jan 20, 2016 $37.99 $37.99 $37.99 $37.99 1 557 900
Jan 19, 2016 $37.55 $37.55 $37.55 $37.55 1 232 500
Jan 15, 2016 $39.90 $39.90 $39.90 $39.90 715 500
Jan 14, 2016 $39.25 $39.25 $39.25 $39.25 707 500
Jan 13, 2016 $38.31 $38.31 $38.31 $38.31 968 000
Jan 12, 2016 $41.24 $41.24 $41.24 $41.24 680 600
Jan 11, 2016 $39.98 $39.98 $39.98 $39.98 962 800
Jan 08, 2016 $40.22 $40.22 $40.22 $40.22 804 400
Jan 07, 2016 $41.01 $41.01 $41.01 $41.01 600 000
Jan 06, 2016 $41.68 $41.68 $41.68 $41.68 624 500
Jan 05, 2016 $42.04 $42.04 $42.04 $42.04 494 200
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT